GSK PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.21 USD | -0.79% |
|
-7.95% | +11.20% |
| 08/06 | US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59 | RE |
| 07/06 | GSK says FDA Approves Expanded Age Indication For Arexvy, RSV Vaccine For Adults Aged 50-59 At Increased Risk | RE |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GSK PLC | Other Pharmaceuticals | -0.79% | -7.95% | +11.20% | +19.94% | -17.17% | 8.45TCr | - | - | - |
- Stock Market
- Equities
- GSK Stock
- GSK Stock
- Charts GSK plc
- Relative Strength Chart
